Response to bortezomib in refractory type I cryoglobulinemia

American Journal of Hematology

Volumn 83, Issue 11, 2008, Pages 883-884

  Talamo, Giampaolo ^a   Claxton, David ^a   Tricot, Guido ^b   Fink, Louis ^c   Zangari, Maurizio ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c NEVADA CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; MELPHALAN; PREDNISONE; VINCRISTINE;

ACROCYANOSIS; ADULT; BONE MARROW BIOPSY; CASE REPORT; CRYOGLOBULINEMIA; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HAND FOOT SYNDROME; HEMOGLOBIN BLOOD LEVEL; HUMAN; JOINT STIFFNESS; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PLASMAPHERESIS; POLYARTHRITIS; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; SYNOVITIS; TREATMENT RESPONSE; TYPE 1 CRYOGLOBULINEMIA; VASCULITIC RASH; VASCULITIS;

BORONIC ACIDS; CRYOGLOBULINEMIA; HUMANS; MALE; MIDDLE AGED; PROTEASE INHIBITORS; PYRAZINES; VASCULITIS;

EID: 55549148776     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21258     Document Type: Letter

References (3)

1. Tedeschi A, Barate C, Minola E, Morra E. Cryoglobulinemia. Blood Rev 2007;21:183-200.
2. Winfield JB. Cryoglobulinemia. Hum Pathol 1983;14:350-354.
3. Dispenzieri A. Symptomatic cryoglobulinemia. Curr Treat Options Oncol 2000;1:105-118.